Lucas Schulz
Impact in
-
- Antibiotic Use and Resistance
- Clinical Biochemistry top 1%
- Bacterial Identification and Susceptibility Testing
Papers in
-
- Antibiotic Use and Resistance 34
-
- Bacterial Identification and Susceptibility Testing 20
- Co-authors
- Warren E. RoseBarry FoxRavina KullarMichael PostelnickDavid R. AndesGraeme N. ForrestTrevor Van SchooneveldPaul R. Hutson
- Journals
- American Journal of Health-System Pharmacy (8 papers)Open Forum Infectious Diseases (8 papers)Infection Control and Hospital Epidemiology (7 papers)Clinical Infectious Diseases (5 papers)Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (3 papers)
- Partner nations
- United StatesNetherlandsItaly
In The Last Decade
Lucas Schulz
76 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 110
- Applied Microbiology and Biotechnology 388
- Clinical Biochemistry 317
- Molecular Medicine 119
- Infectious Diseases 367
- Geriatrics and Gerontology 76
Countries citing papers authored by Lucas Schulz
This map shows the geographic impact of Lucas Schulz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lucas Schulz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lucas Schulz more than expected).
Fields of papers citing papers by Lucas Schulz
This network shows the impact of papers produced by Lucas Schulz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lucas Schulz. The network helps show where Lucas Schulz may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Lucas Schulz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 4 | |
| 3 | 2023 | 3 | |
| 4 | 2023 | 1 | |
| 5 | 2023 | 5 | |
| 6 | 2023 | 1 | |
| 7 | 2023 | 2 | |
| 8 | 2021 | 5 | |
| 9 | 2021 | 3 | |
| 10 | 2020 | 1 | |
| 11 | 2020 | 19 | |
| 12 | 2020 | 21 | |
| 13 | 2019 | 65 | |
| 14 | 2019 | 16 | |
| 15 | 2018 | 10 | |
| 16 | 2016 | 4 | |
| 17 | 2016 | 8 | |
| 18 | 2014 | 6 | |
| 19 | 2008 | 2 | |
| 20 | 2003 | 33 |
About Lucas Schulz
Lucas Schulz is a scholar working on Applied Microbiology and Biotechnology, Clinical Biochemistry, Infectious Diseases, Pharmacology and Geriatrics and Gerontology, having authored 77 papers that have together received 1.1k indexed citations. Recurring topics across this work include Antibiotic Use and Resistance (34 papers), Bacterial Identification and Susceptibility Testing (20 papers), Antibiotics Pharmacokinetics and Efficacy (18 papers), Antimicrobial Resistance in Staphylococcus (15 papers), Patient Satisfaction in Healthcare (8 papers), Drug-Induced Adverse Reactions (6 papers), Pneumonia and Respiratory Infections (5 papers) and Antibiotic Resistance in Bacteria (5 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (388 citations), Clinical Biochemistry (317 citations), Molecular Medicine (119 citations), Infectious Diseases (367 citations) and Geriatrics and Gerontology (76 citations). Lucas Schulz has collaborated with scholars based in United States, Netherlands and Italy. Frequent co-authors include Warren E. Rose, Barry Fox, Ravina Kullar, Michael Postelnick, David R. Andes, Graeme N. Forrest, Trevor Van Schooneveld, Paul R. Hutson, Andrew D. Berti and Alexander J. Lepak. Their work appears in journals such as American Journal of Health-System Pharmacy, Open Forum Infectious Diseases, Infection Control and Hospital Epidemiology, Clinical Infectious Diseases and Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.